tradingkey.logo

Tempus AI Inc

TEM
66.270USD
-2.090-3.06%
收盘 01/09, 16:00美东报价延迟15分钟
11.78B总市值
亏损市盈率 TTM

Tempus AI Inc

66.270
-2.090-3.06%

关于 Tempus AI Inc 公司

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Tempus AI Inc简介

公司代码TEM
公司名称Tempus AI Inc
上市日期May 30, 2025
CEOLefkofsky (Eric P)
员工数量2400
证券类型Ordinary Share
年结日May 30
公司地址600 West Chicago Avenue
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编60654
电话18335144187
网址https://investors.tempus.com/
公司代码TEM
上市日期May 30, 2025
CEOLefkofsky (Eric P)

Tempus AI Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
752.09K
-135234.00%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
102.70K
-1322.00%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
14.71K
-1997.00%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
10.43K
-2447.00%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-17168.00%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
3.61K
-250.00%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
1.25K
-1997.00%
Mr. Eric P. Lefkofsky, J.D.
Mr. Eric P. Lefkofsky, J.D.
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Erik J. Phelps, J.D.
Mr. Erik J. Phelps, J.D.
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
--
--
Dr. Jennifer A. Doudna, Ph.D.
Dr. Jennifer A. Doudna, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
752.09K
-135234.00%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
102.70K
-1322.00%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
14.71K
-1997.00%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
10.43K
-2447.00%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-17168.00%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
3.61K
-250.00%

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Blue Media, LLC
10.49%
BK TL21 LLC
8.80%
Lefkofsky (Eric Paul)
6.77%
Baillie Gifford & Co.
5.61%
The Vanguard Group, Inc.
5.45%
其他
62.88%
持股股东
持股股东
占比
Blue Media, LLC
10.49%
BK TL21 LLC
8.80%
Lefkofsky (Eric Paul)
6.77%
Baillie Gifford & Co.
5.61%
The Vanguard Group, Inc.
5.45%
其他
62.88%
股东类型
持股股东
占比
Corporation
29.32%
Investment Advisor
28.43%
Investment Advisor/Hedge Fund
11.60%
Individual Investor
7.45%
Research Firm
5.19%
Hedge Fund
4.27%
Holding Company
3.13%
Venture Capital
0.91%
Bank and Trust
0.88%
其他
8.83%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
708
89.83M
51.96%
-1.45M
2025Q3
619
75.72M
43.81%
-4.20M
2025Q2
501
136.83M
81.41%
-3.18M
2025Q1
444
136.54M
81.24%
-3.30M
2024Q4
259
141.87M
89.45%
+26.80M
2024Q3
171
136.39M
89.94%
+26.38M
2024Q2
115
132.44M
88.72%
+132.44M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Blue Media, LLC
18.14M
10.49%
-7.69M
-29.78%
Aug 08, 2025
BK TL21 LLC
15.22M
8.8%
--
--
Mar 18, 2025
Lefkofsky (Eric Paul)
11.70M
6.77%
-16.83K
-0.14%
Nov 25, 2025
Baillie Gifford & Co.
9.69M
5.61%
-2.40M
-19.86%
Sep 30, 2025
The Vanguard Group, Inc.
9.42M
5.45%
+1.70M
+22.05%
Sep 30, 2025
Gray Media, LLC
9.27M
5.36%
-133.25K
-1.42%
Aug 08, 2025
Red Sky LLC
8.06M
4.66%
-1.44M
-15.13%
Sep 30, 2025
ARK Investment Management LLC
7.18M
4.15%
-246.00K
-3.31%
Sep 30, 2025
SoftBank Group Corp
5.41M
3.13%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.38M
3.11%
+2.26M
+72.19%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ARK Genomic Revolution ETF
12.02%
ARK Innovation ETF
5.1%
Global X HealthTech ETF
4.22%
Franklin Genomic Advancements ETF
3.92%
Renaissance IPO ETF
3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
3.05%
AXS Green Alpha ETF
2.92%
ROBO Global Artificial Intelligence ETF
2.49%
First Trust Health Care Alphadex Fund
2.42%
Innovator IBD 50 Fund ETF
2.22%
查看更多
ARK Genomic Revolution ETF
占比12.02%
ARK Innovation ETF
占比5.1%
Global X HealthTech ETF
占比4.22%
Franklin Genomic Advancements ETF
占比3.92%
Renaissance IPO ETF
占比3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
占比3.05%
AXS Green Alpha ETF
占比2.92%
ROBO Global Artificial Intelligence ETF
占比2.49%
First Trust Health Care Alphadex Fund
占比2.42%
Innovator IBD 50 Fund ETF
占比2.22%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Tempus AI Inc的前五大股东是谁?

Tempus AI Inc 的前五大股东如下:
Blue Media, LLC持有股份:18.14M,占总股份比例:10.49%。
BK TL21 LLC持有股份:15.22M,占总股份比例:8.80%。
Lefkofsky (Eric Paul)持有股份:11.70M,占总股份比例:6.77%。
Baillie Gifford & Co.持有股份:9.69M,占总股份比例:5.61%。
The Vanguard Group, Inc.持有股份:9.42M,占总股份比例:5.45%。

Tempus AI Inc的前三大股东类型是什么?

Tempus AI Inc 的前三大股东类型分别是:
Blue Media, LLC
BK TL21 LLC
Lefkofsky (Eric Paul)

有多少机构持有Tempus AI Inc(TEM)的股份?

截至2025Q4,共有708家机构持有Tempus AI Inc的股份,合计持有的股份价值约为89.83M,占公司总股份的51.96%。与2025Q3相比,机构持股有所增加,增幅为8.16%。

哪个业务部门对Tempus AI Inc的收入贡献最大?

在--,--业务部门对Tempus AI Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI